Provectus Biopharmaceuticals Inc PVCT
Trading Information
- Previous Close Price
- $0.05
- Day Range
- $0.05–0.05
- 52-Week Range
- $0.04–0.08
- Bid/Ask
- $0.05 / $0.05
- Shares Outstanding
- 420.28M
- Market Cap
- $20.47M
- Volume/Avg
- 8,028 / 125,142
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Provectus Biopharmaceuticals Inc is a clinical-stage biotechnology company developing immunotherapy medicines for different diseases based on a class of bioactive synthetic small molecule halogenated xanthenes (HXs). Its flagship HX molecule is named rose bengal sodium (RBS). The company's proprietary, patented, pharmaceutical-grade RBS is the active pharmaceutical ingredient (API) in all its clinical development and non-clinical research programs. It has one operating and reporting segment, namely, the development of immunotherapy medicines.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Growth
- Total Number of Employees
- 6
- Website
- https://www.provectusbio.com
Valuation
|
Metric
|
PVCT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
PVCT
Financial Strength
|
Metric
|
PVCT
|
|---|---|
Quick Ratio | 0.15 |
Current Ratio | 0.18 |
Interest Coverage | −23.06 |
Quick Ratio
PVCT
Profitability
|
Metric
|
PVCT
|
|---|---|
Return on Assets (Normalized) | −458.60% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
PVCT
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|?@gVH^ | LOCK|%tJJ | $127B | |||
| Moderna Inc
MRNA
| LOCK|?@#jm&L | LOCK|gH | $87B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|srS#c^C | LOCK|Q<&@h | $81B | |||
| argenx SE ADR
ARGX
| LOCK|#XF!y& | LOCK|h< | $51B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|y>FYj$ | LOCK|JD | $44B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|XNsng#$ | LOCK|&<@? | $31B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|&@TZ!!^ | LOCK|y^%%x | $27B | |||
| Incyte Corp
INCY
| LOCK|>&H!?< | LOCK|>$% | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|DBBmw?& | LOCK|x>w | $22B | |||
| Jazz Pharmaceuticals PLC
JAZZ
| LOCK|qctHh#& | LOCK|WZ% | $14B |
United States